Oramed Pharmaceuticals Inc. maintains a Hold rating as it pivots from drug development to strategic

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million) Scilex (NASDAQ: SCL

NEW YORK, June 17, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www

Oramed Pharmaceuticals is downgraded from 'Strong Buy' to 'Hold' due to the failed phase 3 trial for

Akanda (NASDAQ: AKAN - Get Free Report) and Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report)

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innova

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innov

Position s Lifeward as a diversified biomedical innovation company with clear path to profitability

Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report) and GN Store Nord (OTCMKTS:GNNDY - Get Free

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP - Get Free Report)'s stock price passed above its 50-day m

QuidelOrtho (NASDAQ: QDEL - Get Free Report) and Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Rep

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP - Get Free Report)'s stock price crossed above its 50-day

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotec

Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Pos

Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Conver

Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Conver

Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report) and GE HealthCare Technologies (NASDAQ: GEHC

Oramed remains viable after its flagship product failed FDA trials three years ago. Management ident

Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the

Oramed Advancing Oral Insulin Program Independently; Announces Launch of New U.S. Trial  Diversified

JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”)

  On Thursday, 29 stocks made new 52-week lows.

  On Wednesday, 807 companies reached new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

    On Monday, 721 companies achieved new lows for the year.

  On Friday, 431 companies hit new 52-week lows.

  On Wednesday, 160 companies hit new 52-week lows.

    On Monday, 466 companies hit new 52-week lows.

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969.

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte

    Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs.

    This morning 113 companies reached new 52-week highs.

    Before 10 a.m. ET on Friday, 175 companies set new 52-week highs.

    This morning 121 companies reached new 52-week highs.

  Before 10 a.m. ET on Thursday, 258 companies set new 52-week highs.

    During Wednesday's morning trading, 251 companies set new 52-week highs.

    During Tuesday's morning trading, 67 companies set new 52-week highs.

    During Thursday's morning session, 255 companies made new 52-week highs.

    Before 10 a.m. ET on Wednesday, 192 companies set new 52-week highs.

  On Tuesday morning, 172 companies achieved new highs for the year.

    During the morning session on Monday, 372 stocks hit new 52-week highs.

Gainers AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC) shares jumped 104% to close at $7.1